SciHub
文献互助
期刊查询
一搜即达
科研导航
交流社区
登录
注册
发布
文献
求助
首页
我的求助
捐赠本站
已入深夜,您辛苦了!由于当前在线用户较少,发布求助请尽量完整的填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!祝你早点完成任务,早点休息,好梦!
郭政飞
Lv3
220 积分
2023-06-01 加入
最近求助
最近应助
互助留言
NF-κB represses E-cadherin expression and enhances epithelial to mesenchymal transition of mammary epithelial cells: potential involvement of ZEB-1 and ZEB-2
2小时前
待确认
CDK4/6 inhibitors in breast cancer: spotting the difference
5天前
已完结
Monitoring APOBEC3A protein levels in human cancer cells
1个月前
已完结
Discovery of GDC-0077 (Inavolisib), a Highly Selective Inhibitor and Degrader of Mutant PI3Kα
3个月前
已完结
Drug-tolerant persister cells in cancer: the cutting edges and future directions
4个月前
已完结
AXL activates YAP through the EGFR–LATS1/2 axis and confers resistance to EGFR-targeted drugs in head and neck squamous cell carcinoma
4个月前
已完结
Exploring the next generation of antibody–drug conjugates
4个月前
已完结
The antibody-drug conjugate landscape
4个月前
已完结
Dalpiciclib plus letrozole or anastrozole versus placebo plus letrozole or anastrozole as first-line treatment in patients with hormone receptor-positive, HER2-negative advanced breast cancer (DAWNA-2): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial
5个月前
已完结
Dalpiciclib plus letrozole or anastrozole versus placebo plus letrozole or anastrozole as first-line treatment in patients with hormone receptor-positive, HER2-negative advanced breast cancer (DAWNA-2): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial
5个月前
已完结
H 2 ‐Directing Strategy on In Situ Synthesis of Co‐MoS 2 with Highly Expanded Interlayer for Elegant HER Activity and its Mechanism
1年前
已驳回
感谢,点赞,速度真快
5天前
感谢,点赞
1个月前
感谢
4个月前
感谢,速度真快,点赞
4个月前
感谢
4个月前
感谢,点赞
4个月前
感谢,点赞,速度真快
5个月前
点赞
5个月前
感谢
5个月前
速度真快
8个月前
最近帖子
最近评论
没有发布任何帖子
没有发布任何评论